CD44 and breast carcinoma: Flow cytometry data showed that all parental cancer cell lines and hybrid clone cells exhibited the putative breast cancer stem/ initiating cell phenotype CD44+/CD24−/low, which has been demonstrated to determine a highly tumorigenic breast cancer cell population [37].